Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | REGN7075 |
Trade Name | |
Synonyms | REGN-7075|REGN 7075 |
Drug Descriptions |
REGN7075 is a bispecific antibody targeting EGFR and CD28, which may trigger cytotoxic T-lymphocytes-mediated immune response against EGFR-expressing tumor cells (NCI Thesaurus). |
DrugClasses | EGFR Antibody 60 |
CAS Registry Number | NA |
NCIT ID | C178284 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cemiplimab + REGN7075 | Cemiplimab REGN7075 | 0 | 2 |
REGN7075 | REGN7075 | 0 | 1 |